CD8A and neoplasm: Furthermore, specific microbial taxa enhance CD8+ T cell cytotoxicity, as evidenced by Baruch et al. Research by Baruch et al. (2021), who reported improved anti-tumor immunity through microbiota-driven CD8+ T cell priming.